Understanding Nail Dystrophy and Related Skin Disorders

Apr 5


David Peter Jones

David Peter Jones

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Nail dystrophy encompasses a range of nail abnormalities, often characterized by misshapen or partially destroyed nail plates. This condition can arise from various causes, including reduced blood flow, trauma, fungal infections, and skin diseases like psoriasis. Accurate diagnosis is crucial, as nail dystrophy can mimic other conditions such as onychomycosis, a common fungal nail infection. This article delves into the causes, symptoms, and treatment options for nail dystrophy, providing insights into this often-overlooked aspect of dermatological health.

The Impact of Trauma on Nail Health

Subungual Hematoma and Its Consequences

When the fingertips sustain an injury,Understanding Nail Dystrophy and Related Skin Disorders Articles a subungual hematoma, or collection of blood under the nail, can form. This condition can cause severe pain, which may be alleviated by creating a small hole in the nail plate to release the pressure. However, significant hematomas can lead to the nail plate's eventual detachment and may result in permanent scarring, thickening, and ridging of the nail. Scarred nails are particularly susceptible to onychomycosis, a fungal infection. Unfortunately, even surgical removal of the scarred nail often results in the regrowth of a similarly dystrophic nail.

Onychomycosis: A Common Culprit

Signs and Progression of Fungal Nail Infections

Onychomycosis is a prevalent cause of nail dystrophy, especially in the great toenails. It typically begins with onycholysis at the nail's distal tip, followed by the accumulation of soft, yellow keratin that causes the nail to lift further. Over time, the nail becomes misshapen and thickened, which can be asymptomatic unless it starts pressing against footwear. The primary pathogen responsible for onychomycosis is Trichophyton rubrum, although other fungi like Epidermophyton floccosum and Trichophyton mentagrophytes can also be involved. Treatment usually involves oral antifungal medications like griseofulvin or, less commonly, ketoconazole. Topical treatments are generally ineffective. Fingernail infections may clear within 3 to 6 months of treatment, while toenails, with their slower growth, require 9 to 12 months. Despite treatment, recurrence rates are high, leading some healthcare providers to question the value of treating toenail onychomycosis.

Age-Related Susceptibility and Treatment Outcomes

The likelihood of developing onychomycosis increases with age, with children being rarely affected. According to a study published in the Journal of Clinical and Aesthetic Dermatology, nearly 50% of nail dystrophies are due to fungal infections, with the prevalence rising significantly in older populations. The success rate of treatment for fingernail infections is high, but toenail infections are more challenging, with a lower response rate to therapy. Recurrence is common, with some studies suggesting a recurrence rate of over 40% within two years after successful treatment, as reported by the American Academy of Dermatology.

Psoriasis and Nail Dystrophy

Psoriatic Nail Changes and Their Variability

Nail dystrophy is also a significant concern for patients with psoriasis, with nail involvement occurring in a substantial number of cases. Psoriatic nail changes can manifest in various forms, depending on whether the nail matrix or nail bed is affected. Onycholysis is a common sign of nail bed pathology, while "oil spots" and pitting are indicative of nail matrix involvement. Advanced disease can lead to severely misshapen nails and may be associated with psoriatic arthritis.

Challenges in Treating Psoriatic Nail Dystrophy

Treatment options for psoriatic nail dystrophy are limited and often unsatisfactory. Topical steroids, either applied directly or under occlusion, may offer minimal improvement. Intralesional steroid injections can be more effective but are painful and not well-tolerated by patients. Some success has been reported with topical fluorouracil, while systemic treatments like methotrexate and etretinate can clear nails but carry the risk of significant side effects. Improvement in nail dystrophy may coincide with the remission of cutaneous psoriatic lesions, whether spontaneous or treatment-induced.


Nail dystrophy is a multifaceted condition with various causes and manifestations. Accurate diagnosis, often involving KOH preparations and fungal cultures, is essential for effective management. While treatment options exist, they are not universally successful, and recurrence is common. Ongoing research and advancements in dermatological treatments may provide better outcomes for those affected by nail dystrophy in the future.

For more detailed information on nail health and disorders, the American Academy of Dermatology provides extensive resources and guidelines.